Stay updated on Adagrasib Combo in KRAS G12C Clinical Trial

Sign up to get notified when there's something new on the Adagrasib Combo in KRAS G12C Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adagrasib Combo in KRAS G12C Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added site 007-436 in Pergamino, Argentina (B2700KMP) and updated contact details for Eva-Lotte Buchmeier (site 2217) and Ullrich Graeven (site 2221). The total number of locations is now 756.
    Difference
    0.1%
    Check dated 2026-02-20T16:49:25.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.2, replacing Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T12:48:08.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Added Instituto de Oncologia de Rosario (Site 007-5004) with Lucas Lucchesi Bosco; removed Sang-We Kim (Site 007-104). Updated the email line requirement to include NCT # and Site #, and added IPD sharing information with the provided URL and Revision: v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-05T23:50:37.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Study locations increased to 755 with new sites and contacts added, and certain contacts were removed or updated.
    Difference
    0.1%
    Check dated 2026-01-29T22:33:28.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Added recruitment site Tampereen Yliopistollinen Sairaala (TAYS) in Finland (Site 007-182) with investigator Jarkko Johannes Ahvonen; the site status updated to Recruiting. Updated the Last Update Posted timestamp to 2026-01-16.
    Difference
    0.0%
    Check dated 2026-01-20T18:28:57.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Added new site contacts: Docrates Cancer Center (Tuomo Alanko, Site 007-183, +358505001850), Asklepios Kliniken Barmbek (Robert Erdmann, Site Erdmann, R., +49401818828494), and Lee Chern Siang (Site 007-095); added Istanbul University Cerrahpasa Fak. Hastanesi contact Mustafa Ozguroglu (Site 007-062, 905324167355). Removed existing contacts for Erdmann, R. (Site 007-183), Terence Aik Huang Tan (Site 007-095), and the Local Institution entry for Site 007-062 dated 2025-12-22.
    Difference
    0.1%
    Check dated 2026-01-13T14:51:19.000Z thumbnail image

Stay in the know with updates to Adagrasib Combo in KRAS G12C Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adagrasib Combo in KRAS G12C Clinical Trial page.